AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

Summary

The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.

Eligibility

Inclusion Criteria:

* Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary molecular test (biomarker) prior to their resection (biopsy) diagnosis or recurrence,
* AND adult (equal to or \> 18 years old),
* AND affiliated with a social security scheme in France,
* AND whose monitoring will be carried out at the recruiting center.

Exclusion Criteria:

* Patient being monitored for a non-urothelial bladder tumor
* Patient refusing follow-up
* Opposition to participation in the study
* Adult protected by law

Conditions2

Browse More Trials